Skip to content

Clinical trials

Phase 3 Leukemia trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 3 Country / region: Russia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20111
20121
20141
20151
20161
20172
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AbbVie1
Acerta Pharma BV1
Amgen1
Antisoma Research1
Celgene1
Daiichi Sankyo1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Gilead Sciences1
Institut de Recherches Internationales Servier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia13
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Myeloid, Acute4
Bronchiolitis Obliterans Syndrome2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid2
Bone Marrow Diseases1
Hematologic Neoplasms1
Leukemia, B-Cell1
Lymphatic Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.